On May 22, BAYZED HEALTH (02609) announced that Ms. Liu Yan has resigned from her position as Vice President of the company due to her intention to dedicate more time and effort to her other affairs. According to the announcement, Ms. Liu Yan possesses over 30 years of management experience in the healthcare industry. She joined BAYZED HEALTH in February 2025. Her professional background is as follows: From July 2024 to February 2025, she served as Assistant President at New Journey Health Technology Group Co., Ltd. From February 2023 to July 2024, she held the position of Assistant President at New Journey Health Group. From June 2019 to February 2023, she was Vice President and Chief Financial Officer at Beijing Hongci Medical Group. From September 2017 to June 2019, she served as Chief Financial Officer and Head of Operations at Beijing Hongci Medical Group. From March 2017 to September 2017, she was Financial Director at Beijing Hongci Medical Group. From July 1995 to March 2017, she served as Director of the Management Department at the Fifth Medical Center of the Chinese PLA General Hospital.

On September 26 last year, BAYZED HEALTH announced the appointment of Ms. Liu Yan as Vice President, which was less than a year ago. BAYZED HEALTH was established in 2017. On June 23, 2025, the company successfully listed on the Main Board of The Stock Exchange of Hong Kong Limited. It is a Chinese medical group focused on comprehensive tumor cycle management, building an eight-link service system covering "prevention, screening, diagnosis, treatment, rehabilitation, management, connection, and companionship," which spans the entire chain of tumor screening, diagnosis, treatment, and rehabilitation. Headquartered in Beijing with a nationwide business layout, the company is committed to establishing a benchmark for private tumor medical services.